| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Anaesthetics and Intensive Care Medicine, The Queen's University of Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL N. Ireland, UK.
Address correspondence to: Dr. R.K. Mirakhur, Phone: 44-28-9033-5785; Fax: 44-28-9032-9605; E-mail: r.mirakhur{at}qub.ac.uk
Purpose: To examine the influence of continuing administration of sevoflurane or isoflurane during reversal of rocuronium induced neuromuscular block with neostigmine.
Methods: One hundred and twenty patients, divided into three equal groups, were randomly allocated to maintenance of anesthesia with sevoflurane, isoflurane or propofol. Neuromuscular block was induced with rocuronium and monitored using train-of-four (TOF) stimulation of the ulnar nerve and recording the force of contraction of the adductor pollicis muscle. Neostigmine was administered when the first response in TOF had recovered to 25%. At this time the volatile agent administration was stopped or propofol dosage reduced in half the patients in each group (n = 20 in each group). The times to attain TOF ratio of 0.8, and the number of patients attaining this end point within 15 min were recorded.
Results: The times (mean ± SD) to recovery of the TOF ratio to 0.8 were 12.0 ± 5.5 and 6.8 ± 2.3 min in the sevoflurane continued and sevoflurane stopped groups, 9.0 ± 8.3 and 5.5 ± 3.0 min in the isoflurane continued and isoflurane stopped groups, and 5.2 ± 2.8 and 4.7 ±1.5 min in the propofol continued and propofol stopped groups (P < 0.5- 01). Only 9 and 15 patients in the sevoflurane and isoflurane continued groups respectively had attained a TOF ratio of 0.8 within 15 min (P < 0.001 for sevoflurane).
Conclusions: The continued administration of sevoflurane, and to a smaller extent isoflurane, results in delay in attaining adequate antagonism of rocuronium induced neuromuscular block.
This article has been cited by other articles:
![]() |
L. M. Staals, M. M. J. Snoeck, J. J. Driessen, E. A. Flockton, M. Heeringa, and J. M. Hunter Multicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function Br. J. Anaesth., October 1, 2008; 101(4): 492 - 497. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Flockton, P. Mastronardi, J. M. Hunter, C. Gomar, R. K. Mirakhur, L. Aguilera, F. G. Giunta, C. Meistelman, and M. E. Prins Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine Br. J. Anaesth., May 1, 2008; 100(5): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Kim, M. A. Cheong, H. J. Lee, and J. M. Lee Tactile Assessment for the Reversibility of Rocuronium-Induced Neuromuscular Blockade During Propofol or Sevoflurane Anesthesia Anesth. Analg., October 1, 2004; 99(4): 1080 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. El-Orbany and A. A. Dahaba Short-acting neuromuscular blocking drugs allow better control of OR time Can J Anesth, June 1, 2002; 49(6): 635 - 635. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |